M. D. Anderson's Thoracic Center is dedicated to improving outcomes for patients with all stages of lung and chest cancers.
Our surgeons, oncologists and radiation therapists collaborate to treat mesothelioma and cancers of the lung, esophagus, trachea, chest wall, pericardium and pulmonary system, which often require more than one type of treatment.

M. D. Anderson constantly employs new and advanced technologies and treatment options, and we benchmark against national cancer standards to ensure that we achieve the best outcomes possible for our patients. In fact, when compared against data from the Surveillance, Epidemiology, and End Results (SEER) program, M. D. Anderson’s five-year outcomes outperformed national survival statistics for both early and late stage lung cancer. M. D. Anderson achieved five-year survival rates of more than 30% higher than the SEER average for lung cancers overall and more than 35% higher for patients with early stage lung cancer.

As with any cancer, ensuring the best treatment requires accurate diagnosis and staging. M. D. Anderson offers the latest diagnostic techniques available, such as positron emission tomography (PET), high resolution CT scanning, endobronchial and esophageal ultrasound and advanced bronchoscopic imaging. 

Our innovative cancer treatments include advanced and minimally invasive surgery techniques, proton beam radiation therapy, and access to the latest drugs that specifically target cancer cells. The integration of these therapies allows M. D. Anderson to achieve the best possible outcome for patients with thoracic cancers. 

Getting the right diagnosis and treatment from the start can make all of the difference in your fight against cancer.